Valiant Co.,Ltd (SZSE: 002643)
Materials · Chemicals · CN
CN¥13.88
-2.73% today · +0.4% 1Y
Valiant Co.,Ltd (SZSE: 002643) operates in the Chemicals industry within the Materials sector. The company is valued at $1.89B and employs 4,887 people.
Over the last twelve months the share price has gained 0.4%, trading between 12.20 and 22.22.
Tweenvest scores Valiant Co.,Ltd across four factors: quality 70/100, value 26/100, growth 18/100, dividend 54/100. Its strongest factor is quality.
002643 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.89B
- Revenue (TTM)
- $563.85M
- P/E
- 51.84
- EPS
- 0.27
- Dividend yield
- 0.90%
- Beta (5Y)
- 0.85
- 52-week high
- CN¥22.22
- 52-week low
- CN¥12.20
- Avg volume (3M)
- —
- Shares outstanding
- 915.90M
- Employees
- 4,887
- Next earnings
- —
About Valiant Co.,Ltd
Valiant Co.,Ltd., a global enterprise established in 1992, specializes in the worldwide production and distribution of an extensive array of chemical materials. The company's diverse product portfolio primarily encompasses electronic chemicals, including components and intermediates vital for liquid crystal displays (LCDs) and organic light-emitting diodes (OLEDs), as well as polyimide (PI) materials, photoresist (PR) monomers, and crucial additives for lithium-ion batteries. Beyond electronics, Valiant provides various specialized materials for environmental and industrial applications. These include substances for automotive exhaust purification, catalysts for flue gas denitrification, volatile organic compound (VOC) adsorption, methanol-to-olefin conversion, and petroleum cracking. Furthermore, the company contributes to the new energy sector with advanced materials, energy-efficient lighting solutions, organic solar technologies, and ancillary components for electric vehicles. Valiant's operations also extend into the life sciences and healthcare domains. It manufactures Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and finished drug formulations, alongside traditional Chinese medicine products and nutritional health supplements. The company supports scientific research through life science products and services relevant to drug innovation, genomics, proteomics, metabolomics, and food health analysis. Additionally, Valiant develops diagnostic reagents essential for identifying human diseases such as AIDS, hepatitis, cancer, dengue fever, and cardiovascular/cerebrovascular conditions, as well as for detecting drug abuse, endocrine levels, and other physiological parameters. Originally known as Yantai Valiant Fine Chemicals Co., Ltd., the company rebranded to Valiant Co.,Ltd. in May 2015. It is headquartered in Yantai, China.
- ISIN
- CNE1000019T0
- Founded
- 1992
- Listed since
- Dec 20, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Linde plcNasdaqGS: LIN | $224.76B | $490.03 | +0.50% |
| L'Air Liquide S.A.ENXTPA: AI | $124.17B | €167.70 | +0.35% |
| The Sherwin-Williams CompanyNYSE: SHW | $83.64B | $346.73 | +0.04% |
| Ecolab Inc.NYSE: ECL | $78.95B | $286.98 | +1.90% |
| Shin-Etsu Chemical Co., Ltd.TSE: 4063 | $70.78B | ¥6,051.00 | -1.79% |
| Air Products and Chemicals, Inc.NYSE: APD | $67.94B | $306.24 | +0.37% |
| Corteva, Inc.NYSE: CTVA | $54.57B | $82.81 | +1.25% |
| BASF SEXTRA: BAS | $51.93B | €52.43 | +1.47% |
Figures last refreshed Aug 18, 2026.